The outbreak of Acinetobacter baumannii producing OXA-23 and OXA-51 type carbapenemases in a state hospital

Year 2016, Volume: 33 Issue: 3, 157 - 161, 06.01.2017

Tulin Guven Gokmen , Beril Akcimen Begum Kayar Mahdi Marzi Fatih Koksal

Abstract

Acinetobacter baumannii is non-fermentative gram-negative bacilli which plays an important pathogen especially in intensive care units causing infections and epidemics. Carbapenem resistance often is consisted of OXA-type carbapenemase. In this study, we aimed to determine carbapenem resistance and clonal relationships of A. baumannii isolated from patient and enviromental samples by phenotypic and genotypic methods in 10-bed intensive care unit. Multiplex-PCR method was used to determine the genes of OXA type beta-lactamases (blaOXA) and clonal relations between strains were investigated by pulsed-field gel electrophoresis (PFGE) method. All of the isolates were found to be carbapenem resistant and had the blaOXA-51-like and blaOXA-23-like gene. Also, all of isolates were seen to be 100 % related by PFGE method. As a result, isolates of patients with ventilator-associated pneumonia and isolates survived on ventilator of Intensive Care Unit were found to be 100% clonal associated with PFGE and had same MIC values for imipenem and meropenem. blaOXA-23 and blaOXA-51 genes has been determined all of the isolates. It can be accepted a short-term and small outbreak.

Keywords

A. baumannii, Outbreak, OXA-23, OXA-51

References

• Arıkan, A.Ö., 2003. Acinetobacter baumannii izolatlarında antibiyotik direnci: 2002 yılı İbni Sina Hastanesi verileri, Mikrobiyol. Bült. 37, 241-246.
• Arslan, H., 2014. Acinetobacter moleküler epidemiyolojisi. ANKEM. 28, 71-72.
• Balcı, M., Bitirgen, M., Kandemir, B., Arıbaş, E.T., Erayman, I., 2010. Antibiotic susceptibility of nosocomial acinetobacter baumannii strains. 24, 28-33.
• Bergogne-Bérézin, E., Towner, K.J., 1996. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9, 148-165.
• Durmaz, R., Otlu, B., Koksal, F., Hosoglu, S., Ozturk, R., Ersoy, Y., Aktas, E., Gursoy, N.C., Caliskan, A., 2009. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn. J. Infect. Dis. 62, 372-327.
• Ertürk, A., Çiçek, A.Ç., Gümüş, A, Cüre, E., Şen, A., Kurt, A., Karagöz, A., Aydoğan, N., Sandallı, C., Durmaz, R., 2014. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units. Ann. Clinic. Microbiol. Antimicrob. 13, 36. doi:10.1186/s12941-014-0036-2.
• European Commitee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Versions3.1.Available:http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_ table_v_3.1.pdf Accessed 10 May 2014.
• Gözütok, F., Sarıgüzel, F.M., Çelik, İ., Berk, E., Aydın, B., Güzel, D., 2013. Hastane infeksiyonu etkeni acinetobacter baumannii suşlarının antimikrobiyal direnç oranlarının araştırılması. ANKEM. 27, 7-12.
• Gökmen, T.G., Güran, M., Benk, I.G., Kızılyıldırım, S., Köksal, F., 2012. Yanık ünitesinde kısa-dönem/uzun-dönem acinetobacter baumannii salgını. Ankem. 26, 120-125.
• Héritier, C., Poirel, L., Nordmann, P., 2006. Cephalosporinase overexpression as a result of insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12, 123-130. doi: 10.1111/j.1469-0691.2005.01320.x.
• Inchai, J., Pothirat, C., Bumroongkit, C., Limsukon, A., Khositsakulchai, W., Liwsrisakun, C., 2014. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. J. Inten. Care. 3, 9. doi: 10.1186/ s40560-015-0077-4.
• Karabay, O., Yahyaoğlu, M., Öğütlü, A., Sandıkçı O, Tuna N, Ceylan S., 2012. Factors associated with mortality in acinetobacter baumannii infected intensive care unit patients. Mikrobiyol. Bul. 46, 335-337.
• Kohlenberg, A., Brümmer, S., Higgins, P.G., Sohr, D., Piening, B.C., De Grahl., C., Halle, E., Rüden, H., Seifert, H., 2009. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J. Med. Microbiol. 58, 1499-1507. doi: 10.1099/jmm.0.012302-0.
• Moniri, R., Kheltabadi, Farahani, R., Shajari, G.H., Nazem, Shirazi, M.H., Ghasemi, A., 2010. Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. with emergence of multidrug-resistant strains. Iran. J. Public. Health. 39, 63-68.
• Naas, T., Poirel, L., Nordmann, P., 2006. Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type β-lactamases in Acinetobacter baumannii. Clinic. Microbiol. Infect. 12, 1236-1240. doi:10.1111/j.1469-0691.2006.01563.x.
• Nasr, R.A., Attalah, M.F., 2012. Molecular epidemiology of nosocomial acinetobacter baumannii isolates. Nat. Sci. 10, 76-82.
• Nhu, N.T.K., Lan, N.P.H., Campbell, J.I, Parry, C.M., Thompson, C., Tuyen, H.T., et al., 2014. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J. Med. Microbiol. 63, 1386-1394. doi:10.1099/jmm.0.076646-0.
• Papp-Wallace, K.M., Endimiani, A., Taracila, M.A, Bonomo, R.A., 2011. Carbapenems: Past, present, and future. Antimicrob. Agents. Chemother. 55, 4943-4960. doi: 10.1128/AAC.00296-11.
• Peleg, A.Y., Seifert, H., Paterson, D.L., 2008. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-82. doi: 10.1128/CMR.00058-07.
• Poirel, L., Nordmann, P., 2006. Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836. doi: 10.1111/j.1469-0691.2006.01456.x.
• Queenan, A,M., Bush, K., 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20, 440-458. doi: 10.1128/ CMR.00001-07 doi: 10.1128/CMR.00001-07.
• Sabat, A.J., Budimir, A., Nashev, D., Sá-Leão, R., van Dijl, J.M., Laurent, F., Grundmann, H., Friedrich, A.W., 2013. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Eurosurveill. 18, 1-14.
• Sarı, A.N., Biçmen, M., Gülay, Z., 2013. The first report on the outbreak of OXA-24/40-like carbapenemase-producing Acinetobacter baumannii in Turkey. Jpn. J. Infec.t Dis. 66, 439-442.
• Taşova, Y., Akgün, Y., Saltoğlu, N., Yılmaz, G., Kara, O., Dündar, I.H., 1999. Nozokomiyal Acinetobacter infeksiyonları. Flora. 4, 170-176.
• Turton, J.F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M.E., Pitt, T.L., 2006a. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976. doi: 10.1128/ JCM.01021-06.
• Turton, J.F., Ward, M.E., Woodford, N., Kaufmann, M.E., Pike, R., Livermore, D.M, Pitt, T.L., 2006b. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS. Microbiol. Lett. 258, 72-77. doi: 10.1111/j.1574- 6968.2006.00195.x.
• Woodford, N., Ellington, M.J., Coelho, J.M., Turton, J.F., Ward, M.E., Brown, S., Amyes, S.G., Livermore, D.M., 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents. 27, 351-353. doi: DOI: 10.1016/j.ijantimicag.2006.01.004